Analogously, Finegoldii-derived lipoprotein can enhance the expression of CXCL16 in CCR7+ DCs by activating the NF-κB signaling pathway and then promote CD8+ T-cell chemotaxis and invasion through the CXCL16-CXCR6 axis, effectively inhibiting tumor growth [172]. Here, CD8A is linked to neoplasm.